Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - gentamicinum - wirkstoffhaltiger schwamm 5 x 5 x 0,5 cm - gentamicini sulfas 50 mg corresp. gentamicinum 32.5 mg collagenum nativum 70 mg, pro praeparatione. - impianto osseo o infezioni dei tessuti molli - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - gentamicinum - wirkstoffhaltiger schwamm 10 x 10 x 0,5 cm - gentamicini sulfas 200 mg corresp. gentamicinum 130 mg, collagenum nativum 280 mg, pro praeparatione. - impianto osseo o infezioni dei tessuti molli - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - betamethasonum, gentamicinum - crema - betamethasonum 0.5 mg ut betamethasoni dipropionas, gentamicinum 1.0 mg ut gentamicini sulfas, natrii dihydrogenophosphas dihydricus, acidum phosphoricum, paraffinum liquidum, alcohol cetylicus et stearylicus 72 mg, macrogoli aether cetostearylicus, vaselinum album, natrii hydroxidum, aqua purificata, chlorocresolum 1 mg ad emulsionem pro 1 g. - infiammatoria secondaria batterico infetti dermatosi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - betamethasonum, gentamicinum - salve - betamethasonum 0.5 mg ut betamethasoni dipropionas, gentamicinum 1.0 mg ut gentamicini sulfas, paraffinum liquidum, vaselinum album, ad unguentum pro 1 g. - infiammatoria secondaria batterico infetti dermatosi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - betamethasonum, clotrimazolum, gentamicinum - creme - betamethasonum 0.5 mg ut betamethasoni dipropionas, clotrimazolum 10 mg, gentamicinum 1 mg ut gentamicini sulfas, paraffinum liquidum, vaselinum album, alcohol cetylicus et stearylicus 72 mg, propylenglycolum 100 mg, macrogoli aether cetostearylicus, alcohol benzylicus 10 mg, natrii dihydrogenophosphas dihydricus, acidum phosphoricum concentratum, natrii hydroxidum, aqua purificata ad unguentum pro 1 g. - infiammatoria secondaria batterico e/o mykotisch infetti dermatosi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

omnivision ag - diclofenacum natricum, gentamicinum - collirio - diclofenacum natricum 1 mg, gentamicinum 3 mg ut gentamicini sulfas, acidum boricum 13 mg, dinatrii edetas, macrogolglyceroli ricinoleas, natrii chloridum, trometamolum, aqua ad iniectabilia ad solutionem pro 1 ml. - post-operatorio infiammazione della parte anteriore augenabschnittes con il rischio di una infezione batterica - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - haemagglutininum influenzae a (h1n1) (virus-stamm a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-1909 derived from a/guangdong-maonan/swl1536/2019), haemagglutininum influenzae a (h3n2) (virus-stamm a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019), haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) - sospensione iniettabile - haemagglutininum influenzae a (h1n1) (virus-stamm a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-1909 derived from a/guangdong-maonan/swl1536/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus-stamm a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019) 15 µg, haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus-stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.0 mg, kalium 0.1 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum. - aktive immunisierung gegen influenza, ab 3 jahren - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - haemagglutininum influenzae a (h1n1) (virus-stamm a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus-stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-224 derived from a/cambodia/e0826360/2020), haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) - sospensione iniettabile - haemagglutininum influenzae a (h1n1) (virus-stamm a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus-stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-224 derived from a/cambodia/e0826360/2020) 15 µg, haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus-stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.0 mg, kalium 0.1 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum. - aktive immunisierung gegen influenza, ab 6 monaten - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - haemagglutininum influenzae a (h1n1) (virus-stamm a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus-stamm a/darwin/9/2021 (h3n2)-like: reassortant virus derived from a/darwin/9/2021, san-010), haemagglutininum influenzae b (virus-stamm b/austria/1359417/2021 -like: reassortant virus bvr-26 derived from b/austria/1359417/2021 (victoria lineage)) - sospensione iniettabile - haemagglutininum influenzae a (h1n1) (virus-stamm a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus-stamm a/darwin/9/2021 (h3n2)-like: reassortant virus derived from a/darwin/9/2021, san-010) 15 µg, haemagglutininum influenzae b (virus-stamm b/austria/1359417/2021 -like: reassortant virus bvr-26 derived from b/austria/1359417/2021 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus-stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.0 mg, kalium 0.1 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum. - aktive immunisierung gegen influenza, ab 6 monaten - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bavarian nordic switzerland ag - virus fsme inactivatus (stamm k23) - sospensione iniettabile - vaccinum adsorbatum: virus fsme inactivatus (stamm k23) 1.5 µg, trometamolum, aluminium ut aluminii hydroxidum hydricum ad adsorptionem, saccharum, natrii chloridum corresp. natrium 0.94 mg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: formaldehydum, neomycini hydrochloridum, chlortetracyclinum, gentamicini sulfas. - immunizzazione attiva contro l'encefalite da zecche, che abbiano compiuto il 12. anni - vaccini